Login

Luke J. Burchill, M.B.B.S., Ph.D. Cardiologist, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Dr. Burchill shares his perspective on what makes Mayo Clinic’s approach to ACHD special.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Embracing Change: Navigating Through COVID-19 and Beyond
00:10:00
Barksdale Resources: Unveiling Promising Base Metal Exploration at One-to-One Mining Conference in New York
00:00:00
Francois Martelet, CEO, Oasmia Pharmaceutical
00:10:00
Bessemer supports founders and CEOs from their early days through every stage of growth|Mary D'Onofrio,Partner,Bessemer Venture Partners
00:00:00
Kathriena Greenwell, M.D. Bariatric Surgery (Weight-loss Surgery)
00:10:00
Unlocking Success with Our Technical Advisory Services Team | Rajiv Sharma, Group CEO, Coats Group PLCCOA:LSE
00:10:00
Hydrogen technology company discusses major contracts and factory progress | Damien Havard, CEO,Hydrogene De France SA.
00:10:00
Martin Vohánka, CEO of Eurowag, Shares the Company’s Vision and Ambition | Martin Vohánka, CEO, W.A.G. Payment Solutions PLC.
00:10:00
Concurrent Technologies CEO, Dr. Miles Adcock, Unveils Strategic Vision at Cenkos Growth & Innovation Forum | Miles Adcock, CEO of concurrent technologies plc
00:10:00
Developing exciting new x-ray technology that greatly enhances image quality at the Silicon Slopes Tech Summit|Sunny S Sanyal. President/CEO, Varex Imaging Corp
00:10:00
Invests in founders building technology to transform the foundational industries that provide us with the food we eat|Dayna Grayson,Co-Founder and General Partner,Construct Capital
00:10:00
ROCA Industry’s Strong First Semester Results and Market Outlook | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.

© 2026 Nehu